In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund
In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund

In conversation with Alok Agarwal, Senior Fund Manager - Equity, PGIM India Mutual Fund

Corporate earnings growth is coming back and economic recovery is on track.

Shashikant Singh Article rating: 4.0

As we enter 2022, we have the risk of rate hikes and valuations. However, the Indian market has deepened for all start-ups and the outlook is bright for the longer term, asserts Alok Agarwal, Senior Fund Manager-Equity, PGIM India Mutual Fund.

Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar
Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar

Ajooni Biotech trading near 52-week high; to benefit from strategic agreement with IFFCO Kisan Sanchar

Company will have to create a nationwide logistic network to execute the orders through the already established dealer and distributor network of IKSL

Shashikant Singh Article rating: 2.3

Company's shares are trading near 52-week high after entering into a strategic and exclusive agreement with IFFCO KISAN Sanchar.

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

Karan Dsij Article rating: 4.3

With volatility abating and across-the-board buying interest witnessed on Wednesday, we have prepared a list of stocks based on the T20 breakout system, which has the potential to outperform in the near term.    

Overnight Digest : Stocks to be watched on February 10
Overnight Digest : Stocks to be watched on February 10

Overnight Digest : Stocks to be watched on February 10

Coal India, Maruti Suzuki, Hindalco, IndusInd Bank and Bajaj Auto were the top Nifty gainers, while losers were ONGC, Sun Pharma, BPCL, ITC and SBI Life Insurance.

Shreya Chaware Article rating: 4.3

On Wednesday, the benchmark indices ended in green for the second consecutive day on February 9 keeping eyes on MPC meeting outcome.

Days movers take cue from positive market sentiment and corporate earnings
Days movers take cue from positive market sentiment and corporate earnings

Days movers take cue from positive market sentiment and corporate earnings

Abbott India surged 7.38 percent after the company posted 11.78 percent jump in its Q3 revenue at Rs 1,224.36 crore

Shreya Banthia Article rating: 5.0

Gains across sectors gave impetus to the headline indices higher with auto and financials showing strength. The gains extended to broader market with BSE 500 gaining 1.09 per cent or 256 points to close at 23861.29 

Abbott India, Laxmi Machine Works and Sundaram Clayton were among the day’s movers on BSE 500

January 2022 AUM of domestic mutual fund stands at Rs 38.01 lakh crore
January 2022 AUM of domestic mutual fund stands at Rs 38.01 lakh crore

January 2022 AUM of domestic mutual fund stands at Rs 38.01 lakh crore

The debt-oriented fund saw an increase in AUM from Rs 14.04 lakh crore in the month of December 2021 to Rs 14.13 lakh crore in the month of January 2022

Shashikant Singh Article rating: 2.5

Domestic mutual fund AUM saw a marginal increase of 0.8 per cent on monthly basis in the month of January 2022. 

Intraday Spotlight: Shares of SBI Cards and Payment Services rise 5 per cent
Intraday Spotlight: Shares of SBI Cards and Payment Services rise 5 per cent

Intraday Spotlight: Shares of SBI Cards and Payment Services rise 5 per cent

In Q3, the company clocked a 24 per cent YoY growth in its topline.

Anthony Fernandes Article rating: 4.9

Shares of SBI Cards and Payment Services, one of two state-run credit card issuing companies in the country was among the top gainers on the S&P BSE 500 intraday today. The stock was trading up by 5 per cent in the afternoon trading session on Wednesday and was among the top gainers on the BSE 500.  

In conversation with Nikhil Chopra, CEO and Whole-Time Director, J.B. Chemicals and Pharmaceuticals Ltd
In conversation with Nikhil Chopra, CEO and Whole-Time Director, J.B. Chemicals and Pharmaceuticals Ltd

In conversation with Nikhil Chopra, CEO and Whole-Time Director, J.B. Chemicals and Pharmaceuticals Ltd

Progressive policies by the government can help increase the growth trajectory of the Indian pharmaceutical sector, believes Nikhil Chopra, CEO and Whole-time Director, J.B. Chemicals and Pharmaceuticals Ltd.

Armaan Madhani Article rating: 4.6

Progressive policies by the government can help increase the growth trajectory of the Indian pharmaceutical sector, believes Nikhil Chopra, CEO and Whole-time Director, J.B. Chemicals and Pharmaceuticals Ltd. 

RSS
First20182019202020212023202520262027Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR